Z-0466-2022 Class II Terminated

Recalled by Ion Beam Applications S.A. — Louvain-la-neuve, N/A

FDA device recall Z-0466-2022 was initiated by Ion Beam Applications S.A. on Nov 29, 2021 and is designated Class II. Reason for recall: Proton Therapy System (PTS) software can be started in the clinical environment (clinical user) while some processes are still running in the test environment (tcs user). Initiating the startup of… The recall status is terminated (terminated Feb 20, 2024). Affected quantity: 5 devices.

Recall details

Product Type
Devices
Report Date
Jan 19, 2022
Initiation Date
Nov 29, 2021
Termination Date
Feb 20, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5 devices

Product description

Proteus 235; Version: PTS-8 versions before PTS-8.7.2

Reason for recall

Proton Therapy System (PTS) software can be started in the clinical environment (clinical user) while some processes are still running in the test environment (tcs user). Initiating the startup of the clinical processes in the environment is not prevented even if some processes of the test environment (tcs) are still running. It may lead to situations where the system is using test processes without notifying the clinical user. If the versions of the processes are different between both environments, this could have an impact on patient treatments.

Distribution pattern

IN USA: VA, OK, NJ, TN OUS: Czech Republic.

Code information

PAT.108 (US), PAT.110 (US), PAT.113 (US), PAT.114 (EU), SAT.119 (US).

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0466-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0466-2022. Report a data issue: hello@regdatalab.com.